Throughout the last three months, 4 analysts have evaluated Zynex (NASDAQ:ZYXI), offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of recent ...
RBC Capital downgraded Zynex (ZYXI) to Sector Perform from Outperform with a price target of $5.50, down from $11. The firm says the company’s “disappointing update” on its Q4 earnings call suggests a ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ICU Medical (ICUI – Research Report) and Zynex (ZYXI – Research Report). Effectively assess a stock's ...
Zynex, Inc. (NASDAQ:ZYXI – Free Report) – Research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for Zynex in a report issued on Wednesday, March 12th. HC Wainwright ...
Zynex Inc. (ZYXI) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.10 per share a year ago. These figures ...
NEW YORK, March 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results